GLP-1 agonists: what’s the hype about?
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.| Labiotech.eu
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.| Labiotech.eu
The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery.| Labiotech.eu
